BSXNEUTRAL

BSX Revenue Growth (YoY) Analysis

11.6%

Higher than 67% of Healthcare sector peers

Updated 245h ago·SEC filings & market data

Key Takeaway

Revenue Growth (YoY) measures the percentage increase in a company's sales compared to the same quarter one year earlier.

Sector Performance

67th percentile

BSX

11.6%

Sector Median

10.0%

Sector Avg

12.8%

📊

Deep Analysis

Revenue Growth (YoY) measures the percentage increase in a company's sales compared to the same quarter one year earlier.

BSX's current 11.6% growth means its revenue expanded at that rate over the past year. This outpaces the Healthcare sector median of 6.2%, placing BSX in the 72nd percentile among its peers — a strong relative performance. However, no prior data is available for year-over-year change, quarter-over-quarter change, or the last eight quarters, so there is no information on whether this growth rate is accelerating or slowing. Lacking a trend, the high level alone indicates below-average risk from a revenue perspective, but the absence of momentum data limits the picture. This metric supports the overall NEUTRAL verdict because the strong level is a positive sign, yet without a trend to confirm direction, it does not justify a bullish or bearish tilt.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about BSX?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does BSX's Revenue Growth (YoY) compare to its sector?

BSX's Revenue Growth (YoY) of 11.6% compares to a Healthcare sector median of 10.0%, placing it in the 67th percentile.

Who are BSX's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), DGX (10.2%), RMD (10.8%), CAH (11.0%), ABT (7.8%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

Advertisement

Master BSX's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BSX research report

Free account — no credit card

BSX

11.6%

Sector Median

10.0%

Sector Avg

12.8%

How BSX's Revenue Growth (YoY) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.